← Back to Screener
Humacyte, Inc. Warrant (HUMAW)
Price$0.08
Favorite Metrics
Price vs S&P 500 (26W)-81.93%
Price vs S&P 500 (4W)-24.83%
All Metrics
Price vs S&P 500 (YTD)-22.83%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.02M
52-Week High$0.65
26-Week Price Return-73.18%
13-Week Price Return-45.38%
3-Month Return Std Dev156.55%
Year-to-Date Return-19.85%
5-Day Price Return-24.82%
Month-to-Date Return-17.83%
Price vs S&P 500 (13W)-48.25%
Beta2.62x
52-Week Low$0.06
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
HUMAWHumacyte, Inc. Warrant | — | — | — | — | $0.08 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Humacyte develops acellular bioengineered tissues for regenerative medicine, focusing on vascular grafts and engineered organs for vascular trauma, peripheral arterial disease, and dialysis access. The company's pipeline includes tissue-engineered vessels and advanced organ systems designed to address significant patient needs across multiple therapeutic areas.